P.E.R.F.E.C.T.-ing the Pharmaceutical Packaging Selection Process

P.E.R.F.E.C.T.-ing the Pharmaceutical Packaging Selection Process

Globally, injectable drug products accounted for over $530 billion dollars in sales in 2022. This will nearly double by 2032. More importantly, injectables save millions of lives every year – from insulin to heparin to vaccinations, modern medicine would simply not exist without them.

In the packaging of these life-saving products, elastomeric components (stoppers and plungers) are typically used as closures for glass or polymer vial, syringe, and cartridge systems. Choosing the correct elastomeric components can be tough – there are many factors to consider, and competing products on the market can make the decision confusing.

In this blog series, we will examine seven criteria to weigh when selecting the P.E.R.F.E.C.T. rubber closure components, including:

• Particulate
• Extractables & Leachables
• Regulatory
• Functionality
• Engineering Capabilities
• Container Closure Integrity
• Total Quality